Bloodstream infections among intestinal and multivisceral transplant recipients

To examine the etiologies, risk factors, and microbiology of bloodstream infections (BSIs) among intestinal and multivisceral transplant recipients in the 2‐year post‐operative period.

[1]  J. Timpone,et al.  Intra‐abdominal infections among adult intestinal and multivisceral transplant recipients in the 2‐year post‐operative period , 2019, Transplant infectious disease : an official journal of the Transplantation Society.

[2]  G. Selvaggi,et al.  Bloodstream infection caused by enteric organisms during the first 6 months after intestinal transplant , 2019, Transplant infectious disease : an official journal of the Transplantation Society.

[3]  T. Unno,et al.  Sex Differences in Gut Microbiota , 2019, The world journal of men's health.

[4]  A. Nüssler,et al.  Organ transplantation and gut microbiota: current reviews and future challenges. , 2018, American journal of translational research.

[5]  W. Xu,et al.  Risk factors of bloodstream infections in recipients after liver transplantation: a meta-analysis , 2018, Infection.

[6]  L. Abbo,et al.  Clinical outcomes of intestinal transplant recipients colonized with multidrug‐resistant organisms: a retrospective study , 2017, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  A. Van Gossum,et al.  Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure. , 2017, Clinical nutrition.

[8]  V. Allareddy,et al.  The impact of septicemia occurring during hospitalization for renal transplantation procedures on outcomes in adults in United States , 2017, PloS one.

[9]  R. Hotchkiss,et al.  Epidemiology of Bloodstream Infections in a Multicenter Retrospective Cohort of Liver Transplant Recipients , 2015, Transplantation direct.

[10]  W. Xie,et al.  Bloodstream infections among solid organ transplant recipients: epidemiology, microbiology, associated risk factors for morbility and mortality. , 2014, Transplantation reviews.

[11]  T. Fishbein,et al.  Infection among adult small bowel and multivisceral transplant recipients in the 30‐day postoperative period , 2013, Transplant infectious disease : an official journal of the Transplantation Society.

[12]  K. Abu-Elmagd,et al.  Immunologic Challenges in Small Bowel Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  A. Kalil,et al.  Bloodstream Infections During the First Year After Pediatric Small Bowel Transplantation , 2012, The Pediatric infectious disease journal.

[14]  J. Timpone,et al.  Six‐month incidence of bloodstream infections in intestinal transplant patients , 2012, Transplant infectious disease : an official journal of the Transplantation Society.

[15]  A. Moreno,et al.  Early bacteremia after solid organ transplantation. , 2009, Transplantation proceedings.

[16]  E. Steiger,et al.  Collaborative Strategies to Reduce Mortality and Morbidity in Patients With Chronic Intestinal Failure Including Those Who Are Referred for Small Bowel Transplantation , 2008, Transplantation.

[17]  D. Farmer,et al.  Morbidity and mortality associated with chronic intestinal failure. , 2008, Transplantation.

[18]  J. Reyes,et al.  BACTERIAL TRANSLOCATION IN CLINICAL INTESTINAL TRANSPLANTATION , 2000, Transplantation.

[19]  G. Mazariegos,et al.  Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. , 2000, Transplantation.

[20]  G. Talamini,et al.  Survival rate and prognostic factors in patients with intestinal failure. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[21]  S. Ishiyama.  [Intestinal transplantation]. , 1968, Nihon Ishikai zasshi. Journal of the Japan Medical Association.